Interpharm Holdings, Inc.
IPAH · OTC
6/30/2007 | 6/30/2006 | 6/30/2005 | 6/30/2004 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.00 | 0.02 | 0.00 |
| FCF Yield | -2,626.83% | -1,179.75% | -3,312.62% | -328.98% |
| EV / EBITDA | -3.34 | -4.55 | 14.58 | 0.95 |
| Quality | ||||
| ROIC | -19.50% | -7.03% | -0.16% | 10.11% |
| Gross Margin | 28.66% | 27.51% | 22.73% | 23.83% |
| Cash Conversion Ratio | 1.00 | -0.21 | 15.79 | 0.68 |
| Growth | ||||
| Revenue 3-Year CAGR | 23.72% | 15.52% | 0.75% | -8.16% |
| Free Cash Flow Growth | -266.51% | 42.36% | -355.40% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -3.23 | -4.39 | 14.31 | 0.83 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 3.12 | 5.28 | 3.45 | 5.66 |
| Cash Conversion Cycle | 54.07 | 50.53 | 102.14 | 72.14 |